Trade Bayer ^BAYGn

Pivot Bio Names Jason Hoag Head of North American Commercial Distribution | Morningstar

Cytokinetics, Bayer ink pact to develop HCM investigational drug Aficamten in Japan, ETPharma

Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan - November 20, 2024 - Zacks.com

Bayer AG shares target cut to EUR25 from EUR29 by CFRA By Investing.com

Goldman Sachs maintains Neutral on Cytokinetics, $60 target By Investing.com

Cytokinetics Will Get More Revenue for Marketing Aficamten in Japan

How Bayer, Evonik & Henkel can Reduce Supply Chain Emissions

Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan | The Manila Times

Bayer acquires rights to Cytokinetics' heart drug in Japan By Reuters

MDT perspective: innovative applications of stereotactic body radiation therapy in metastatic castration-resistant prostate cancer

CREDIT RESEARCH: Healthcare: Week In Review

Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback - November 15, 2024 - Zacks.com

Cash-strapped US farmers switch to generic crop chemicals, in blow to big manufacturers By Reuters

Kepler Capital Remains a Hold on Bayer (0P6S)

Bayer Cropsc. Share Price Today (19 Nov, 2024), Bayer Cropsc. - Bayer Cropscience Stock Price (₹ 5665.90) Live NSE/BSE, Bayer Cropsc. Shares

Hedge Fund and Insider Trading News: D.E. Shaw, David Einhorn, Israel Englander, Scott Bessent, Casdin Capital, Two Sigma Advisors, Brigade Capital, Rockwell Automation Inc (ROK), Gartner Inc (IT), and More

Daybreak Nov. 13: Senate Rs make their choice

Bayer AG (BAYRY) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges By GuruFocus

Q3 2024 Bayer AG Earnings Call Transcript

D.E. Shaw takes $1 billion short on Bayer, regulatory filing shows By Reuters

Bayer's Near-Term Outlook Dominated by Crop Science Uncertainty and Generic Pressures | Morningstar

DAX Index News: Will US CPI & Tariffs Push DAX Toward 18,750? Key Analysis Inside | FXEmpire

Gracie Abrams Scores First U..K No. 1 Single With 'That's So True'

Bayer Stock Slips On Q3 Loss, Cautious Outlook

Bayer Reduces Losses in the First Nine Months and Sales Fall by 2.5%

News Highlights: Top Company News of the Day - Tuesday at 5 AM ET | Morningstar

Bayer Cuts Earnings Target, Warns on Weak Agriculture Market — Update | Morningstar

News Highlights: Top Company News of the Day - Tuesday at 3 AM ET | Morningstar

Bayer Cuts Earnings Target, Posts Net Loss on Agriculture Weakness | Morningstar

Bayer Lowers Earnings Guidance on Weak Crop Unit Performance

Bayer Q3 Loss Narrows; Updates FY Outlook - Quick Facts

EMEA Morning Briefing: Investors Digest Trump Agenda | Morningstar

European markets fall as mining stocks slide; Bayer shares at 20-year lows; Mediobanca down 8%

German chemicals giant Bayer cuts key target amid weedkiller woes

Bayer shares plunge on weak Q3, guidance cut By Investing.com

Bayer shares slump after warning on crop sciences unit | Morningstar

Group blasts reformulated Roundup weedkiller as more toxic